|
Status |
Public on Nov 13, 2021 |
Title |
genomic DNA from glioblastoma 111 |
Sample type |
genomic |
|
|
Source name |
glioblastoma 111
|
Organism |
Homo sapiens |
Characteristics |
diagnosis: glioblastoma gender: female age: 83 idh: wildtype
|
Treatment protocol |
Standard Illumina EPIC Protocol
|
Extracted molecule |
genomic DNA |
Extraction protocol |
genomic DNA was extracted and purified from LBC samples using Qiagen DNeasy Kit according to standard instructions
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina EPIC Protocol
|
|
|
Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation27 Beadchip using standard Illumina protocol
|
Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting
|
Data processing |
BeadStudio software v3.2
|
|
|
Submission date |
Nov 10, 2021 |
Last update date |
Nov 14, 2021 |
Contact name |
Richard Drexler |
E-mail(s) |
r.drexler@uke.de
|
Organization name |
Medical Center Hamburg-Eppendorf
|
Department |
Neurosurgery
|
Street address |
Martinistraße 52
|
City |
Hamburg |
ZIP/Postal code |
20246 |
Country |
Germany |
|
|
Platform ID |
GPL21145 |
Series (1) |
GSE188547 |
DNA Methylation subclass Receptor Tyrosine Kinase II (RTK II) is predictive for seizure development in glioblastoma patients |
|